OTCMKTS:MPHMF - Callitas Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0928 -0.01 (-9.73 %)
(As of 02/17/2019 11:25 AM ET)
Previous Close$0.0928
Today's Range$0.0928 - $0.0928
52-Week Range$0.0684 - $0.2680
Volume10,000 shs
Average Volume3,400 shs
Market Capitalization$132,425.60
P/E RatioN/A
Dividend YieldN/A
Callitas Health Inc., a biomedical technology company, develops and commercializes technologies for obesity, weight management, and female health and wellness in Canada. The company offers obesity drug C-103, a reformulation of Orlistat; ToConceive, a fertility enhancing moisturizer; and Extrinsa for female sexual dysfunction solutions. The company was formerly known as M Pharmaceutical Inc. and changed its name to Callitas Health Inc. in September 2017. Callitas Health Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

Receive MPHMF News and Ratings via Email

Sign-up to receive the latest news and ratings for MPHMF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Crude petroleum & natural gas



Sales & Book Value

Annual SalesN/A



Market Cap$132,425.60
OptionableNot Optionable

Callitas Health (OTCMKTS:MPHMF) Frequently Asked Questions

What is Callitas Health's stock symbol?

Callitas Health trades on the OTCMKTS under the ticker symbol "MPHMF."

How were Callitas Health's earnings last quarter?

Callitas Health Inc (OTCMKTS:MPHMF) issued its earnings results on Thursday, November, 29th. The company reported ($0.01) earnings per share for the quarter. The company earned $0.16 million during the quarter. View Callitas Health's Earnings History.

When is Callitas Health's next earnings date?

Callitas Health is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Callitas Health.

Has Callitas Health been receiving favorable news coverage?

Headlines about MPHMF stock have trended negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Callitas Health earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future.

Who are some of Callitas Health's key competitors?

Who are Callitas Health's key executives?

Callitas Health's management team includes the folowing people:
  • Mr. George Tsafalas, Sr. Bus. Consultant (Age 50)
  • Mr. James M. Thompson, Interim CEO & Pres
  • Mr. Gary L. Stephens, Chief Financial Officer
  • Mr. Christopher Mothersele, VP of Operations
  • Mr. Joshua Maurice, Director of Sales & Marketing

How do I buy shares of Callitas Health?

Shares of MPHMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Callitas Health's stock price today?

One share of MPHMF stock can currently be purchased for approximately $0.0928.

How big of a company is Callitas Health?

Callitas Health has a market capitalization of $132,425.60.

MarketBeat Community Rating for Callitas Health (OTCMKTS MPHMF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  145
MarketBeat's community ratings are surveys of what our community members think about Callitas Health and other stocks. Vote "Outperform" if you believe MPHMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MPHMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel